The Cigna Group

CI · NYSE

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▲ 0.0% above current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders1.4%

Institutions92.3%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2013-12-31	2012-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$233.59B	$200.15B	$149.86B	$139.45B	$131.38B	$160.40B	$153.57B	$48.65B	$32.38B	$29.12B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$214.99B	$182.51B	$133.80B	$124.83B	$117.55B	$103.48B	$97.67B	$4.79B	$1.51B	$1.33B
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$9.20B	$9.42B	$8.54B	$8.41B	$7.93B	$8.15B	$8.08B	$4.16B	–	–
Operating income as a percentage of revenue.	3.9%	4.7%	5.7%	6.0%	6.0%	5.1%	5.3%	8.6%	–	–
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$331.00M	$344.00M	$208.00M	$78.00M	$50.00M	$31.00M	$16.00M	$0	$2.00M	$1.00M
Net income divided by the number of shares outstanding — profit attributable to each share.	$22.33	$12.25	$17.57	$21.54	$15.87	$23.17	$13.58	$10.00	$5.28	$5.70
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$22.18	$12.12	$17.39	$21.30	$15.73	$22.96	$13.44	$10.00	$5.18	$5.61

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2013-12-31	2012-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$7.68B	$7.55B	$7.82B	$5.92B	$5.08B	$10.18B	$4.62B	$3.85B	$2.79B	$2.98B
Everything the company owns that has value — cash, property, inventory, investments, and more.	$157.92B	$155.88B	$152.76B	$143.93B	$154.89B	–	$155.77B	$153.23B	–	–
All of the company's interest-bearing borrowings, short and long term combined.	$592.00M	$3.04B	$2.77B	$2.99B	$2.54B	$3.37B	$5.51B	$2.96B	$5.25B	$5.19B
Everything the company owes — debt, unpaid bills, and other obligations.	$116.05B	$114.64B	$106.41B	$98.98B	$107.70B	–	$110.39B	$112.15B	–	–
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$41.71B	$41.03B	$46.22B	$44.87B	$47.11B	–	$45.34B	$41.03B	–	–

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2013-12-31	2012-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$9.60B	$10.36B	$11.81B	$8.66B	$7.19B	$10.35B	$9.48B	$3.77B	$719.00M	$2.35B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	–	–	–	–	–	–	$1.05B	$528.00M	$527.00M	$408.00M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	–	–	–	–	–	–	$8.44B	$3.24B	$192.00M	$1.94B

	You	Peer avg
P/E	11.5	25.9
Revenue Growth	+6.7%	+16.9%
ROE	16.8%	10.8%

The Cigna Group

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison